Source:http://linkedlifedata.com/resource/pubmed/id/11476902
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2001-7-30
|
pubmed:abstractText |
In many types of cancer, p53 frequently accumulates in tumor cells and anti-p53 antibodies can be detected. However, only four CD8(+) T-cell epitopes from p53 have been identified in humans so far. To further analyze the development of a T-cell response against p53, peptides having binding motifs specific for HLA-A1, -A2, -A3, -A24, -B7, -B35, -B44, and -B51 molecules have been defined. The HLA-binding capacity of those peptides was tested, and the stability of formed complexes was defined. Thirteen peptides that bound to HLA-A24 and -B44 molecules are presented. The positive peptides were then used to detect the anti-p53 response of CD8(+) T lymphocytes from patients with bladder cancer. Six peptides, presented by HLA-A2, -B51, or -A24, were able to stimulate T cells from two patients (among 16) with tumor cells that strongly accumulated p53. On the contrary, p53 peptides systematically failed to stimulate T cells from healthy donors or patients with low or undetectable levels of p53 in their tumor cells. These results have led to the identification of four new potential T CD8(+) epitopes from p53: 194-203 associating with HLA-B51 and 204-212, 211-218, and 235-243 associating with HLA-A24.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Epitopes, T-Lymphocyte,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-A Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-A2 Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-A24 Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-B Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-B51 Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Histocompatibility Antigens Class I,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0198-8859
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
62
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
791-8
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11476902-CD8-Positive T-Lymphocytes,
pubmed-meshheading:11476902-Cells, Cultured,
pubmed-meshheading:11476902-Epitopes, T-Lymphocyte,
pubmed-meshheading:11476902-HLA-A Antigens,
pubmed-meshheading:11476902-HLA-A2 Antigen,
pubmed-meshheading:11476902-HLA-A24 Antigen,
pubmed-meshheading:11476902-HLA-B Antigens,
pubmed-meshheading:11476902-HLA-B51 Antigen,
pubmed-meshheading:11476902-Histocompatibility Antigens Class I,
pubmed-meshheading:11476902-Humans,
pubmed-meshheading:11476902-Lymphocyte Activation,
pubmed-meshheading:11476902-Peptides,
pubmed-meshheading:11476902-Protein Binding,
pubmed-meshheading:11476902-Tumor Suppressor Protein p53,
pubmed-meshheading:11476902-Urinary Bladder Neoplasms
|
pubmed:year |
2001
|
pubmed:articleTitle |
Identification of p53 peptides recognized by CD8(+) T lymphocytes from patients with bladder cancer.
|
pubmed:affiliation |
INSERM U445, Laboratoire Associé No9 du Comité de Paris de la Ligue contre le Cancer, Institut Cochin de Génétique Moléculaire, Université René Descartes, Paris, France. ferries@cochin.inserm.fr
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|